Related Experiment Video
Updated: Jun 15, 2025
05:42
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
31.3K
ANXIOLYTICS: Origins, drug discovery, and mechanisms.
Jeffrey M Witkin1, James E Barrett2
1Laboratory of Antiepileptic Drug Discovery, Ascension St. Vincent Hospital, Indianapolis, IN, USA.
Pharmacology, Biochemistry, and Behavior
|August 23, 2024
Summary
New anxiolytic drugs are needed due to the limitations of current medications. Research focuses on novel mechanisms beyond GABA potentiation and monoamine uptake blockade for safer, more effective anxiety treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Anxiety is a common human condition requiring effective management.
- Centuries of psychoactive substance use highlight the ongoing need for anxiolytics.
- Modern anxiolytics, including benzodiazepines, have limitations necessitating new drug development.
Purpose of the Study:
- To review the history and current status of anxiolytic drug development.
- To explore novel mechanisms for next-generation anxiolytics.
- To discuss the concept of an anxioselective drug with improved safety profiles.
Main Methods:
- Historical overview of anxiolytic discovery.
- Discussion of behavioral pharmacology in preclinical development.
- Analysis of diverse molecular targets beyond GABAA potentiation and monoamine uptake.
Main Results:
- Current anxiolytics face challenges with efficacy, side effects, and dependence.
- Novel therapeutic strategies involve targeting mechanisms beyond traditional pathways.
- The development of an anxioselective drug aims to minimize sedation and dependence.
Conclusions:
- Despite existing treatments, there is a significant unmet need for alternative anxiolytic medicines.
- Preclinical and clinical research is actively pursuing novel compounds.
- Identifying safer and more effective anxiolytics remains a critical goal in drug development.
Related Concept Videos
01:26Anxiolytic Drugs: Overview
243
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
243
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
593
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
593
01:23Sedatives and Hypnotics: Overview
312
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
312
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
162
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
162
01:26Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K